Bill Text: US HB2443 | 2015-2016 | 114th Congress | Introduced
Bill Title: To amend the Federal Food, Drug, and Cosmetic Act with respect to CLIA waiver study design guidance for in vitro diagnostics.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2015-05-22 - Referred to the Subcommittee on Health. [HB2443 Detail]
Download: US_Congress-2015-HB2443-Introduced.pdf
